论文部分内容阅读
预防性血小板输注是指通过输注血小板使各种血小板生成障碍患者,如恶性血液病、再生障碍性贫血(aplastic anemia,AA)、骨髓移植等患者的血小板计数(platelet count,PLT)提高到某一安全水平,达到防止出血的目的〔1〕。欧美国家超过70%的血小板输注为预防性输注,根据AABB的调查〔2〕,60%的医疗机构以PLT值20×109/L作为预防性输注的临界值。但由于多次反复输注单采血小板可刺激机体产生血小板相关抗体或(和)血
Prophylactic platelet transfusion refers to the increase in platelet count (PLT) in patients with various types of thrombocytopathy, such as hematologic malignancies, aplastic anemia (AA), and bone marrow transplants, by infusion of platelets A certain level of safety to achieve the purpose of preventing bleeding 〔1〕. More than 70% of platelet transfusions in Europe and the United States as prophylactic infusion, according to the AABB survey [2], 60% of the medical institutions with PLT value of 20 × 109 / L as a prophylactic infusion of the critical value. However, repeated repeated infusion of apheresis platelets can stimulate the body to produce platelet-associated antibodies or (and) blood